Progression Clinical Trials
0 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
Omitting CTV for Primary Tumor in LS-SCLC
Radiotherapy Side EffectProgressionSCLC, Limited Stage+1 more
Sun Yat-sen University852 enrolled2 locationsNCT07008716
Recruiting
Phase 2
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Neuroendocrine TumorsProgressionNeuroendocrine Tumor of Pancreas+4 more
AC Camargo Cancer Center100 enrolled2 locationsNCT06472388
Recruiting
Phase 2
A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules
Progression
Shanghai Zhongshan Hospital120 enrolled1 locationNCT04905056